FDAnews
www.fdanews.com/articles/132495-orthovita-receives-clearance-for-vitoss-bone-graft-substitute

Orthovita Receives Clearance for Vitoss Bone Graft Substitute

December 7, 2010
Orthovita, Inc. … announced Tuesday that it received 510(k) clearance from the U.S. Food and Drug Administration to market Vitoss Bioactive Foam-2X Bone Graft Substitute for use as a non-structural bone void filler for use in the spine, pelvis and extremities.
TradingMarkets